Analysis of Arbidol® Effectiveness agains an Experimental Form of Severe Acute Respiratory Syndrome
https://doi.org/10.24411/0235-2990-2019-100039
Abstract
Studies have been conducted to assess the effectiveness of Arbidol® in relation to the experimental form of severe acute respiratory syndrome in Syrian Golden hamster. It is shown that Arbidol® is most effective when used in therapeutic and prophylactic schemes. The coefficient of therapeutic action for virological, hematological and biochemical parameters was 57.5 and 65.0%, respectively (P<0.05 and P<0.01).
About the Authors
S. Ya. Loginova
48th Central Scientific Research Institute of the Ministry of Defense of the Russian Federation
Russian Federation
Russian Federation
V. N. Shchukina
48th Central Scientific Research Institute of the Ministry of Defense of the Russian Federation
Russian Federation
Russian Federation
S. V. Borisevich
48th Central Scientific Research Institute of the Ministry of Defense of the Russian Federation
Russian Federation
Russian Federation
R. A. Khamitov
OOO International Biotechnology Center «Generium»
Russian Federation
Russian Federation
V. A. Maksimov
48th Central Scientific Research Institute of the Ministry of Defense of the Russian Federation
Russian Federation
Russian Federation
A. M. Shuster
OOO International Biotechnology Center «Generium»; Moscow OAO «Pharmstandard»
Russian Federation
Russian Federation
Review
For citations:
Loginova S.Ya., Shchukina V.N., Borisevich S.V., Khamitov R.A., Maksimov V.A., Shuster A.M. Analysis of Arbidol® Effectiveness agains an Experimental Form of Severe Acute Respiratory Syndrome. Antibiot Khimioter = Antibiotics and Chemotherapy. 2019;64(7-8):19-23. (In Russ.) https://doi.org/10.24411/0235-2990-2019-100039
Views:
409
Email this article 